Somatic mutations of PPP2R1A in ovarian and uterine carcinomas - Wikidata - wikimedia - TriplyDB

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

http://www.wikidata.org/entity/Q34805570

about

The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin PP2A: The Wolf in Sheep's Clothing?Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.Mapping the human phosphatome on growth pathways.Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.Hope for GWAS: relevant risk genes uncovered from GWAS statistical noise.Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.The genomics and genetics of endometrial cancer.B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility Genetic and molecular changes in ovarian cancer.Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.Use of mutation profiles to refine the classification of endometrial carcinomas.Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.Protein phosphatase 2A: a target for anticancer therapy.PPP2R1A mutations are common in the serous type of endometrial cancer.Next-Generation Sequencing.Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors.Mutation spectrum in the Wnt/β-catenin signaling pathway in gastric fundic gland-associated neoplasms/polyps.RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late

P2860

Q26739246-4BBECD83-7827-43AA-9BE7-8576CDE73EBA Q27008375-6697E26D-9CF4-400C-9E51-C3F08837FCB7 Q28088747-C6128232-595F-4190-9005-05AD6BA90074 Q28273722-9B29BA85-8ED8-48BE-88F0-38CB19B7F7EB Q33355350-5B2B5351-3F99-41C1-A525-E1D36AA4C386 Q34294009-E08C924C-472B-4E24-A411-DAFD53B2C8FA Q34350701-9CB2835C-9D8D-4148-85EC-FA1FEC17F253 Q34486620-2B73FA10-39E0-4214-A4AC-67DA705544A9 Q35132338-B3DD55DF-4C09-401E-BFDF-EDA743853791 Q35859963-00923E73-71ED-4122-A20E-5E6758986C64 Q36151896-762C28DA-A0F8-43A7-B025-58F708DE587F Q36216530-9FE5A559-65CE-4AAA-9273-B05B15344D6C Q36294598-3F0957E4-F3D8-4995-B4EC-CC94664363EC Q36447819-92508977-F109-4071-A3A7-4708951E91BF Q36637663-58FC39A8-60A4-483E-9A35-2AF6AC6D0107 Q36974742-72482EBE-42C5-4EF7-A0D8-454B28329F5D Q37068930-04E305BD-11CB-4541-A054-22F74ADD3331 Q37094076-31539F40-66C5-4909-BBA6-61020218AF35 Q37379877-DCBE2F0C-37A4-4F23-9068-9EBDF1F7C6A5 Q37612253-83C669D3-4EA3-4C30-BD25-FB27DBF0B7A8 Q37699264-D2EC6898-B390-4810-9C3F-1EAC7F699673 Q38067436-A3A88E11-F830-4774-AF88-68A681608BE7 Q38103646-49FE4BEC-F6ED-44C2-A433-DDB895160F28 Q39481202-2301C2B2-2161-41C5-AA6B-EF385CDE99F9 Q51032285-3473905E-D4BD-4091-A2D6-EC648D245C93 Q51609445-0541C4CC-2132-4081-A3AE-837E573BA2BA Q53565865-86D324FF-EB35-4109-8817-2C273D407B1D Q55056786-98F97C20-0843-405B-8381-8F3BE7696495 Q57169683-EBD68B6D-64B4-4451-A4EC-2975075BEEFA

P2860

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

http://www.wikidata.org/entity/Q34805570

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@ast

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@en

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@nl

type

label

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@ast

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@en

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@nl

prefLabel

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@ast

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@en

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@nl

P1433

Q34805570-60FC29AF-594D-4972-A9A4-0FDD1D8A97F6

P1476

Q34805570-DA856C06-EC4C-4998-A212-D7BB4E864A6F

P2093

Q34805570-144ED4F7-4E93-415A-B692-D5FF4B01416E

Q34805570-1E3D09A6-620C-45D4-90AB-0CC86CC85544

Q34805570-4D2E65D8-637E-4C83-B735-F78EB8908822

Q34805570-714B3EA7-6305-4F89-8E57-9753E565B6F7

Q34805570-BCB44D99-A5F4-447D-8A5F-A0FE553D47AB

Q34805570-E93B1908-665E-46C0-98B2-C1A986A48277

Q34805570-F038B226-C33E-46F4-97C5-AB4515A51D0D

P2860

Q34805570-03931446-EB59-451B-8312-C2680CDC9741

Q34805570-17396D2E-049B-48B4-9C3B-0D70ACEED967

Q34805570-1845A31B-ED1E-4B75-B8C4-9BA9A878AF9D

Q34805570-1A2AA362-A16D-442E-ACB2-50FB060E3012

Q34805570-2BF3837D-0A9B-4B4C-8C04-A034D7369368

Q34805570-3EBAA253-E0BA-4E7F-837C-B60FB021106E

Q34805570-524E144B-58BC-402A-B05D-E69E29EB1C23

Q34805570-722BEBFA-BC21-439B-8408-AF6104DBA147

Q34805570-74C11ED7-A5E6-49FD-B104-24926CBA1C68

Q34805570-768F882B-21C0-4DE7-B4C1-B6FDC51AB341

P304

Q34805570-CFD0DD01-150E-4620-8C01-4DC48A3C1E9F

P31

Q34805570-5F874FBE-EB85-4F3E-B527-B9976C8BCABA

P356

Q34805570-D2AAC42E-D938-4035-A629-E54847593F9F

P407

Q34805570-D1C80D60-AAB2-4DE6-BD07-F5E51F8ABE59

P433

Q34805570-B0C0F933-CE06-487B-BB1D-5AFC84040DD8

P478

Q34805570-2F3BD37B-746F-465D-8BCB-52E46C48F7DF

P50

Q34805570-31B19A9E-1408-471B-A91A-883012734736

Q34805570-B1D906FC-B1A0-4E1E-B99A-E8A6F2A5E867

P577

Q34805570-12C4A3E5-6685-4FAB-9E45-E5026B865C77

P5875

Q34805570-22A2472C-B9B9-43C3-914C-10F92F4EC596

P698

Q34805570-6351AED3-553F-484B-B399-D7E712D902ED

P932

Q34805570-B3A326D3-6F8E-45AE-8F1E-BB15C7BDC888

P356

J.AJPATH.2011.01.009

P1433

The American Journal of Pathology

P1476

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

@en

P2093

Elisabetta Kuhn

http://www.w3.org/2001/XMLSchema#string

Ie-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Pradeep K Panuganti

http://www.w3.org/2001/XMLSchema#string

Robert J Kurman

http://www.w3.org/2001/XMLSchema#string

Sian Jones

http://www.w3.org/2001/XMLSchema#string

Tian-Li Wang

http://www.w3.org/2001/XMLSchema#string

Tsui-Lien Mao

http://www.w3.org/2001/XMLSchema#string

P2860

Binding specificity of protein phosphatase 2A core enzyme for regulatory B subunits and T antigens

PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma

Serine/threonine protein phosphatases

Association of protein phosphatase 2A with polyoma virus medium tumor antigen

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

Apply innovative technologies to explore cancer genome

DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma

Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme.

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.

P304

1442-1447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2011.01.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Victor Velculescu

P577

2011-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50849885

http://www.w3.org/2001/XMLSchema#string

P698

21435433

http://www.w3.org/2001/XMLSchema#string

P932

3078449

http://www.w3.org/2001/XMLSchema#string